UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 195

Sortiert nach

Hepatocyte growth factor activator inhibitors (HAI‐1 and HAI‐2): Emerging key players in epithelial integrity and cancer

Pathology international, 2018-03, Vol.68 (3), p.145-158

2018

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of hepatocyte growth factor activation in cancer tissues

Cancers, 2014-09, Vol.6 (4), p.1890-1904

2014

Link zum Volltext

Verfügbarkeit prüfen

Hepatocyte growth factor activator (HGFA): pathophysiological functions in vivo

The FEBS journal, 2010-05, Vol.277 (10), p.2230-2237

2010

Link zum Volltext

Verfügbarkeit prüfen

Aberrant methylation and silencing of the SPINT2 gene in high‐grade gliomas

Cancer science, 2018-09, Vol.109 (9), p.2970-2979

2018

Link zum Volltext

Verfügbarkeit prüfen

Ghrelin administration suppresses inflammation‐associated colorectal carcinogenesis in mice

Cancer science, 2015-09, Vol.106 (9), p.1130-1136

2015

Link zum Volltext

Verfügbarkeit prüfen

Role of the polycystic kidney disease domain in matriptase chaperone activity and localization of hepatocyte growth factor activator inhibitor‐1

The FEBS journal, 2022-06, Vol.289 (12), p.3422-3439

2022

Link zum Volltext

Verfügbarkeit prüfen

Decreased prostasin expression is associated with aggressiveness of oral squamous cell carcinoma

Human cell : official journal of Human Cell Research Society, 2021-09, Vol.34 (5), p.1434-1445

2021

Link zum Volltext

Verfügbarkeit prüfen

Loss of hepatocyte growth factor activator inhibitor type 1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation model

Cancer science, 2014-01, Vol.105 (1), p.44-51

2014

Link zum Volltext

Verfügbarkeit prüfen

Adrenomedullin alleviates mucosal injury in experimental colitis and increases claudin‐4 expression in the colonic epithelium

FEBS open bio, 2023-04, Vol.13 (4), p.713-723

2023

Link zum Volltext

Verfügbarkeit prüfen

Protease‐activated receptor‐2 accelerates intestinal tumor formation through activation of nuclear factor‐κB signaling and tumor angiogenesis in ApcMin/+ mice

Cancer science, 2020-04, Vol.111 (4), p.1193-1202

2020

Link zum Volltext

Verfügbarkeit prüfen

Deregulated matriptase activity in oral squamous cell carcinoma promotes the infiltration of cancer‐associated fibroblasts by paracrine activation of protease‐activated receptor 2

International journal of cancer, 2017-01, Vol.140 (1), p.130-141

2017

Link zum Volltext

Verfügbarkeit prüfen

Hepatocyte Growth Factor Activator Inhibitor Type 1 Is a Suppressor of Intestinal Tumorigenesis

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8), p.2659-2670

2013

Link zum Volltext

Verfügbarkeit prüfen

Insufficiency of hepatocyte growth factor activator inhibitor‐1 confers lymphatic invasion of tongue carcinoma cells

Cancer science, 2022-06, Vol.113 (6), p.2179-2193

2022

Link zum Volltext

Verfügbarkeit prüfen

HAI‐2 stabilizes, inhibits and regulates SEA‐cleavage‐dependent secretory transport of matriptase

Traffic (Copenhagen, Denmark), 2017-06, Vol.18 (6), p.378-391

2017

Link zum Volltext

Verfügbarkeit prüfen

Hepatocyte growth factor activator inhibitor-2 stabilizes Epcam and maintains epithelial organization in the mouse intestine

Communications biology, 2019-01, Vol.2 (1), p.11, Article 11

2019

Link zum Volltext

Verfügbarkeit prüfen

CCR4 is expressed on infiltrating cells in lesional skin of early mycosis fungoides and atopic dermatitis

Journal of dermatology, 2015-06, Vol.42 (6), p.613-615

2015

Link zum Volltext

Verfügbarkeit prüfen

Hepatocyte growth factor activator inhibitor type 1 suppresses metastatic pulmonary colonization of pancreatic carcinoma cells

Cancer science, 2011-02, Vol.102 (2), p.407-413

2011

Link zum Volltext

Verfügbarkeit prüfen

Membrane-Bound Serine Protease Inhibitor HAI-1 Is Required for Maintenance of Intestinal Epithelial Integrity

The American journal of pathology, 2011-10, Vol.179 (4), p.1815-1826

2011

Link zum Volltext

Verfügbarkeit prüfen

Hepatocyte growth factor activator inhibitor type-2 (HAI-2)/ SPINT2 contributes to invasive growth of oral squamous cell carcinoma cells

Oncotarget, 2018-02, Vol.9 (14), p.11691-11706

2018

Link zum Volltext

Verfügbarkeit prüfen

IRF-2 haploinsufficiency causes enhanced imiquimod-induced psoriasis-like skin inflammation

Journal of dermatological science, 2018-04, Vol.90 (1), p.35-45

2018

Link zum Volltext

Verfügbarkeit prüfen

Hepatocyte growth factor activator is a serum activator of single‐chain precursor macrophage‐stimulating protein

The FEBS journal, 2009-07, Vol.276 (13), p.3481-3490

2009

Link zum Volltext

Verfügbarkeit prüfen

Prognostic significance of hepatocyte growth factor activator inhibitor type 1 (HAI-1) immunoreactivity in pancreatic ductal adenocarcinoma

BMC research notes, 2017-12, Vol.10 (1), p.674-674, Article 674

2017

Link zum Volltext

Verfügbarkeit prüfen

Loss of membrane-bound serine protease inhibitor HAI-1 induces oral squamous cell carcinoma cells' invasiveness

The Journal of pathology, 2012-10, Vol.228 (2), p.181-192

2012

Link zum Volltext

Verfügbarkeit prüfen

Defect of Hepatocyte Growth Factor Activator Inhibitor Type 1/Serine Protease Inhibitor, Kunitz Type 1 (Hai-1/Spint1) Leads to Ichthyosis-Like Condition and Abnormal Hair Development in Mice

The American journal of pathology, 2008-11, Vol.173 (5), p.1464-1475

2008

Link zum Volltext

Verfügbarkeit prüfen

Activation of macrophage-stimulating protein by human airway trypsin-like protease

FEBS letters, 2012-02, Vol.586 (3), p.217-221

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 195

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(158)
Mit Volltextzugriff
(190)

Publikationsform

Sprache

Englisch
(180)
Japanisch
(72)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Hepatocyte growth factor activator inhibitors (HAI‐1 and HAI‐2): Emerging key players in epithelial integrity and cancer

Mechanisms of hepatocyte growth factor activation in cancer tissues

Hepatocyte growth factor activator (HGFA): pathophysiological functions in vivo

Aberrant methylation and silencing of the SPINT2 gene in high‐grade gliomas

Ghrelin administration suppresses inflammation‐associated colorectal carcinogenesis in mice

Role of the polycystic kidney disease domain in matriptase chaperone activity and localization of hepatocyte growth factor activator inhibitor‐1

Decreased prostasin expression is associated with aggressiveness of oral squamous cell carcinoma

Loss of hepatocyte growth factor activator inhibitor type 1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation model

Adrenomedullin alleviates mucosal injury in experimental colitis and increases claudin‐4 expression in the colonic epithelium

Protease‐activated receptor‐2 accelerates intestinal tumor formation through activation of nuclear factor‐κB signaling and tumor angiogenesis in ApcMin/+ mice

Deregulated matriptase activity in oral squamous cell carcinoma promotes the infiltration of cancer‐associated fibroblasts by paracrine activation of protease‐activated receptor 2

Hepatocyte Growth Factor Activator Inhibitor Type 1 Is a Suppressor of Intestinal Tumorigenesis

Insufficiency of hepatocyte growth factor activator inhibitor‐1 confers lymphatic invasion of tongue carcinoma cells

HAI‐2 stabilizes, inhibits and regulates SEA‐cleavage‐dependent secretory transport of matriptase

Hepatocyte growth factor activator inhibitor-2 stabilizes Epcam and maintains epithelial organization in the mouse intestine

CCR4 is expressed on infiltrating cells in lesional skin of early mycosis fungoides and atopic dermatitis

Hepatocyte growth factor activator inhibitor type 1 suppresses metastatic pulmonary colonization of pancreatic carcinoma cells

Membrane-Bound Serine Protease Inhibitor HAI-1 Is Required for Maintenance of Intestinal Epithelial Integrity

Hepatocyte growth factor activator inhibitor type-2 (HAI-2)/ SPINT2 contributes to invasive growth of oral squamous cell carcinoma cells

IRF-2 haploinsufficiency causes enhanced imiquimod-induced psoriasis-like skin inflammation

Hepatocyte growth factor activator is a serum activator of single‐chain precursor macrophage‐stimulating protein

Prognostic significance of hepatocyte growth factor activator inhibitor type 1 (HAI-1) immunoreactivity in pancreatic ductal adenocarcinoma

Loss of membrane-bound serine protease inhibitor HAI-1 induces oral squamous cell carcinoma cells' invasiveness

Defect of Hepatocyte Growth Factor Activator Inhibitor Type 1/Serine Protease Inhibitor, Kunitz Type 1 (Hai-1/Spint1) Leads to Ichthyosis-Like Condition and Abnormal Hair Development in Mice

Activation of macrophage-stimulating protein by human airway trypsin-like protease

Suchergebnisse filtern